Related Experiment Videos
[Screening hepatitis B virus X-interactive proteins by yeast two-hybrid system]
Dan Li1, Xiao-Zhong Wang, Zhi-Xin Chen
1Department of Gastroenterology, Renmin Hospital, Wuhan University Medicine School, Wuhan, Hubei, 430071, PR China. lidan2006@hotmail.com
AI Zheng = Aizheng = Chinese Journal of Cancer
|May 15, 2004
Summary
This study identified Fis protein as a novel interaction partner of the Hepatitis B virus X protein (HBx) using a yeast two-hybrid system. This interaction is crucial for understanding HBx transactivation and hepatocellular carcinoma development.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus X protein (HBx) is a transactivator implicated in hepatocellular carcinoma.
- Protein-protein interactions are vital for HBx transactivation.
- Identifying HBx interacting proteins is key to understanding its oncogenic mechanisms.
Purpose of the Study:
- To screen and identify novel protein interactors of the Hepatitis B virus X protein (HBx).
- To elucidate the molecular mechanisms underlying HBx-mediated oncogenesis.
- To utilize the yeast two-hybrid system for protein-protein interaction discovery.
Main Methods:
- Construction and validation of an HBx bait plasmid (pAS2-1-X) using yeast two-hybrid system.
- Expression of HBx-BD fusion protein confirmed by Western blot.
- Screening of a human liver cDNA library, followed by beta-gal activity assay, segregation analysis, and mating experiments to identify positive interactors.
Main Results:
- Successful construction and expression of the HBx bait plasmid.
- Identification of a single positive clone after rigorous screening and validation steps.
- Bioinformatic analysis revealed high homology of the interacting protein with the Fis gene.
Conclusions:
- Fis protein is identified as a novel binding partner of the Hepatitis B virus X protein (HBx).
- This interaction was confirmed in vivo using the yeast two-hybrid system.
- The discovery of Fis as an HBx interactor provides new insights into viral oncogenesis.